文献

Background Information:

Darapladib is a selective lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, currently in clinical studies for the treatment of atherosclerosis.

APIM050360: DARAPLADIB (SB-480848)

CAS No.: 356057-34-6.
Molecular Formula: C36H38F4N4O2S.
Molecular Weight: 666.77.
Purity: >99.5% (HPLC at 214 and 254 nm).
QC: 1H-NMR, MS and HPLC.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.